Biotechnology

eTheRNA Immunotherapies, a clinical-stage company developing mRNA-based immunotherapies as off-the-shelf products for the treatment of cancer and infectious diseases, has announced the award of a TIGER grant of €6.9 million from the EU commission. The grant was awarded to a consortium led by eTheRNA and will be used to accelerate the development of a novel, potentially best-in-class therapeutic mRNA cancer […]

Biotechnology company PerkinElmer has announced its documentation, workflow and decision-making informatics platform, Signals, is expanding to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With the collaboration, pharmaceutical and academic research teams can combine the power […]

NanoTemper Technologies will be running a case study and walk through of Prometheus Panta. Join the company on 30 March to learn how to make formulation workflow more efficient with multi-parameter stability characterisation. This event will provide new perspectives on data and will look at how running thermal unfolding, particle sizing, and turbidity measurements simultaneously […]

Axol Bioscience, provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies,  have signed a merger agreement. The new entity will become a provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modelling for drug discovery and screening markets. […]

Bio-Techne, a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities, announced that its Bristol site has received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for research use. ISO 9001:2015 is an internationally recognised quality standard intended to ensure the consistent design, […]

A new report from Invest Stockholm on Advanced Therapeutics Manufacturing and Life Science in the Stockholm region showed that the sector has grown by 66% in the past four years. Collaboration between local tech and pharma industries are expected to further enhance Stockholm’s competitiveness and growth in the future. Both global companies and specialist start-ups […]

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive Covid-19 legacies – including accelerated development timelines, remote trials and new technologies in genetic and target screening. The report anticipates breakthroughs in multi-modal disease therapies within five […]

Albany Molecular Research (AMRI), provider of advanced contract research, development and manufacturing solutions, has been included in America’s Best Employers 2021 list, published by Forbes. AMRI was included in the Drugs and Biotechnology industry category of the ranking. Its 3,100 employees provide scientific solutions across the R&D and manufacturing continuum to pharmaceutical and biotechnology customers. […]

Global biopharmaceutical company Amryt has signed a distribution agreement with Medison Pharma Canada to distribute Myalepta (metreleptin) in Canada. Amryt is a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising novel treatments for rare diseases. Medison is a commercial partner of global biotech companies that provide integrated services for biotech companies looking to […]

Automation software developers Celltrio and Biosero will integrate Biosero’s Green Button Go Automation Scheduling Software with Celltrio’s RoboCell Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a new end-to-end system. The aim is that Green Button Go will accelerate the cell culture and harvesting process, by as much as […]